Implantable and transcutaneous continuous glucose monitoring system: a randomized cross over trial comparing accuracy, efficacy and acceptance

AIM: To compare accuracy, efficacy and acceptance of implantable and transcutaneous continuous glucose monitoring (CGM) systems. METHODS: In a randomized crossover trial we compared 12 weeks with Eversense implantable sensor (EVS) and 12 weeks with Dexcom G5 transcutaneous sensor (DG5) in terms of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Boscari, F., Vettoretti, M., Cavallin, F., Amato, A. M. L., Uliana, A., Vallone, V., Avogaro, A., Facchinetti, A., Bruttomesso, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246426/
https://www.ncbi.nlm.nih.gov/pubmed/34196924
http://dx.doi.org/10.1007/s40618-021-01624-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246426/
https://www.ncbi.nlm.nih.gov/pubmed/34196924
http://dx.doi.org/10.1007/s40618-021-01624-2

Ejemplares similares